EUVIMEDОткрийте EUVIMED
Open access · CC BY 4.0

The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche

Ester Gonzalez-Sanchez, Javier Vaquero iD, Daniel Caballero-Diaz, Jan Grzelak, Noel P Fusté, Esther Bertran, Josep Amengual, Juan Garcia-Saez, Beatriz Martín-Mur, Marta Gut iD, Anna Esteve-Codina, Ania Alay and 7 more

The Journal of Pathology · 2024

DOI: 10.1002/path.6299 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Ester Gonzalez-Sanchez and 18 co-authors. Institution: Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain. Major MEDLINE topics: ErbB Receptors, Hepatocytes, Signal Transduction, Carbon Tetrachloride. Cited 12 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases, CERCA Programme/Generalitat de Catalunya, Fundacion Ramon Areces.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

Liver fibrosis is the consequence of chronic liver injury in the presence of an inflammatory component. Although the main executors of this activation are known, the mechanisms that lead to the inflammatory process that mediates the production of pro‐fibrotic factors are not well characterized. Epidermal growth factor receptor (EGFR) signaling in hepatocytes is essential for the regenerative processes of the liver; however, its potential role in regulating the fibrotic niche is not yet clear. Our group generated a mouse model that expresses an inactive truncated form of the EGFR specifically in hepatocytes (ΔEGFR mice). Here, we have analyzed the response of WT and ΔEGFR mice to chronic treatment with carbon tetrachloride (CCl 4 ), which induces a pro‐inflammatory and fibrotic process in the liver. The results indicated that the hallmarks of liver fibrosis were attenuated in CCl 4 ‐treated ΔEGFR mice when compared with CCl 4 ‐treated WT mice, coinciding with a faster resolution of the fibrotic process and ameliorated damage. The absence of EGFR activity in hepatocytes induced changes in the pattern of immune cells in the liver, with a notable increase in the population of M2 macrophages, more related to fibrosis resolution, as well as in the population of lymphocytes related to eradication of the damage. Transcriptome analysis of hepatocytes, and secretome studies of extracellular media from in vitro experiments, allowed us to elucidate the specific molecular mechanisms regulated by EGFR that mediate hepatocyte production of both pro‐fibrotic and pro‐inflammatory mediators; these have consequences for the deposition of extracellular matrix proteins, as well as for the immune microenvironment. Overall, our study uncovered novel mechanistic insights regarding EGFR kinase‐dependent actions in hepatocytes that reveal its key role in chronic liver damage. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

ErbB ReceptorsHepatocytesSignal TransductionCarbon TetrachlorideAnimalsLiverLiver CirrhosisMiceMice, Inbred C57BLMaleCell CommunicationMacrophagesMice, Transgenic

Author keywords

CCl4cytokinesextracellular matriximmune microenvironmentinflammatory responseintercellular crosstalkliver damageliver fibrosismacrophagessecretome

Substances

ErbB ReceptorsEGFR protein, mouseCarbon Tetrachloride

Authors and institutions

  • Oncobell Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet, Barcelona, Spain.
  • Biomedical Research Networking Center in CIBER in Hepatic and Digestive Diseases (CIBEREHD), ISCIII, Madrid, Spain.
  • Department of Physiological Sciences, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain.
  • Department of Physiology and Pharmacology, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.
  • Centro de Investigación del Cancer and Instituto de Biología Molecular y Celular del Cancer, CSIC-Universidad de Salamanca, Salamanca, Spain.
  • Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain.

ORCID profiles: Javier Vaquero, Marta Gut, Isabel Fabregat

Funding

  • CIBEREHD, National Biomedical Research Institute on Liver and Gastrointestinal Diseases
  • CERCA Programme/Generalitat de Catalunya
  • Fundacion Ramon Areces
  • Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación, Spain
  • European Regional Development Fund
  • Instituto de Salud Carlos III
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
  • Generalitat de Catalunya

Cite

APA

Gonzalez-Sanchez, E., Vaquero, J., Caballero-Diaz, D., Grzelak, J., Fusté, N. P., Bertran, E., Amengual, J., Garcia-Saez, J., Martín-Mur, B., Gut, M., Esteve-Codina, A., Alay, A., Coulouarn, C., Calero-Perez, S., Valdecantos, P., Valverde, A. M., Sánchez, A., Herrera, B., & Fabregat, I. (2024). The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of Pathology. https://doi.org/10.1002/path.6299

Vancouver

Gonzalez-Sanchez E, Vaquero J, Caballero-Diaz D, Grzelak J, Fusté NP, Bertran E, et al. The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche. The Journal of Pathology. 2024. doi:10.1002/path.6299

BibTeX
@article{GonzalezSanchez2024,
  author = {Gonzalez-Sanchez, Ester and Vaquero, Javier and Caballero-Diaz, Daniel and Grzelak, Jan and Fusté, Noel P and Bertran, Esther and Amengual, Josep and Garcia-Saez, Juan and Martín-Mur, Beatriz and Gut, Marta and Esteve-Codina, Anna and Alay, Ania and Coulouarn, Cedric and Calero-Perez, Silvia and Valdecantos, Pilar and Valverde, Angela M and Sánchez, Aránzazu and Herrera, Blanca and Fabregat, Isabel},
  title = {The hepatocyte epidermal growth factor receptor ( EGFR ) pathway regulates the cellular interactome within the liver fibrotic niche},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6299}
}
Start for free →